Total Funding
74
70
Total FundingSeries A raised
Growth Score 74 in past quarter
-12 pts
Heat Score 70 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10868
Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.
Acquired by 
Sensei Biotherapeutics
Anand Parikh: Founder & CEOPast Role: Virta Health, Head of Finance, General Counsel & Corporate Secretary
Ryan Whitney: Head of OperationsPast Role: Virta Health, Strategic Development
About the Company
Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy.
The company was founded to
translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.